Discrimination of Mycobacterium abscessus subsp. massiliense from Mycobacterium abscessus subsp. abscessus in Clinical Isolates by Multiplex PCR [PDF]
Journal of Clinical Microbiology, 2014 ABSTRACT The rapidly growing mycobacterium M. abscessus sensu lato is the causative agent of emerging pulmonary and skin diseases and of infections following cosmetic surgery and postsurgical procedures. M.
Kazue, Nakanaga +9 more
openaire +2 more sources
Mycobacterium abscessus subsp. abscessus canaliculitis [PDF]
Revista Española de Quimioterapia, 2021 M N, Carmona Tello +3 more
openaire +3 more sources
Non-disulfide-Bridge peptide 5.5 from the Scorpion Hadrurus gertschi Inhibits the growth of mycobacterium abscessus subsp. massiliense [PDF]
, 2017 Multi-drug resistant microorganisms have been a growing concern during the last decades due to their contribution in mortality rates worldwide. Antimicrobial peptides (AMPs) are broad spectrum antimicrobial agents that display potent microbicidal ...
Kipnis, Ana Paula Junqueira +8 more
core +1 more source
Outcomes of Pulmonary Mycobacterium abscessus Infection
The International Journal of Mycobacteriology, 2020 Background: Treatment of Mycobacterium abscessus pulmonary disease (PD) is challenging with frequent side effects and uncertain rates of success. Methods: We performed a retrospective review of all patients at our center with at least one respiratory sample positive for M. abscessus
William G Flight +2 more
openaire +3 more sources
Proposal that Mycobacterium massiliense and Mycobacterium bolletii be united and reclassified as Mycobacterium abscessus subsp. bolletii comb. nov., designation of Mycobacterium abscessus subsp. abscessus subsp. nov. and emended description of Mycobacterium abscessus [PDF]
International Journal of Systematic and Evolutionary Microbiology, 2011 The names ‘Mycobacterium abscessus subsp. abscessus’ and ‘Mycobacterium abscessus subsp. massiliense’, proposed by Leao et al. (2009, J Clin Microbiol 47, 2691–2698), cannot be validly published. The purpose of this report is to provide a description in accordance with the Rules of the Bacteriological Code (1990 Revision).
Sylvia Cardoso, Leao +3 more
openaire +2 more sources
Annals of Clinical Microbiology, 2019 Background: Pulmonary infection with nontuberculous mycobacteria (NTM) is increasing in South Korea. Since treatment strategy differs by NTM species, accurate identification is necessary.
Young Sun Joo +4 more
doaj +1 more source
ChemistryOpen, 2020 Non‐tuberculous mycobacterium (NTM) infections, such as those caused by Mycobacterium abscessus, are increasing globally. Due to their intrinsic drug resistance, M.
Dr. Jérôme deRuyck +10 more
doaj +1 more source
Disseminated Mycobacterium abscessus infection and native valve endocarditis
Respiratory Medicine Case Reports, 2021 Mycobacterium abscessus is a rapidly growing mycobacterium. It rarely causes disseminated infection or endocarditis. A 55-year-old male with a history of hepatitis C, liver cirrhosis, intravenous drug use (last use was four years ago), and chronic back ...
Mandeep Singh Rahi +5 more
doaj +1 more source
Virulence-Associated Secretion in Mycobacterium abscessus
Frontiers in Immunology, 2022 Non-tuberculous mycobacteria (NTM) are a heterogeneous group of originally environmental organi3sms, increasingly recognized as pathogens with rising prevalence worldwide. Knowledge of NTM’s mechanisms of virulence is lacking, as molecular research of these bacteria is challenging, sometimes more than that of M.
Michal Bar-Oz +2 more
openaire +3 more sources
Pulmonary Mycobacterium avium-intracellulare is the main driver of the rise in non-tuberculous mycobacteria incidence in England, Wales and Northern Ireland, 2007–2012 [PDF]
, 2016 BACKGROUND: The incidence of non-tuberculous mycobacteria (NTM) isolation from humans is increasing worldwide. In England, Wales and Northern Ireland (EW&NI) the reported rate of NTM more than doubled between 1996 and 2006.
H. Lucy Thomas +7 more
core +4 more sources